53 filings
8-K
XBIT
XBiotech Inc.
20 Jun 24
Submission of Matters to a Vote of Security Holders
12:57pm
8-K
XBIT
XBiotech Inc.
4 Jan 24
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
9:00am
8-K
XBIT
XBiotech Inc.
23 Jun 23
Submission of Matters to a Vote of Security Holders
3:03pm
8-K
XBIT
XBiotech Inc.
14 Feb 23
Departure of Directors or Certain Officers
7:47pm
8-K
XBIT
XBiotech Inc.
29 Jun 22
Submission of Matters to a Vote of Security Holders
11:47am
8-K
52hc 8tsbygdn31
13 May 22
Changes in Registrant's Certifying Accountant
3:01pm
8-K
bwr8rmj4e
2 Feb 22
Entry into a Material Definitive Agreement
4:15pm
8-K
5uv9 xzqz5w
6 Jul 21
XBiotech Announces Dividend to Holders of Common Stock
5:08pm
8-K
24nlx
29 Jun 20
Submission of Matters to a Vote of Security Holders
1:14pm
8-K
6uzcsm8inolhwo5 52c
30 Dec 19
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
5:08pm
8-K
i12uin
9 Dec 19
XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen
4:28pm
8-K
sm4sagrm6lpyvpece
16 Jul 19
XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board
12:36pm
8-K
41no8x9 wh4w6np
20 Jun 19
Submission of Matters to a Vote of Security Holders
1:16pm
8-K
4zlkegvg 7h1
3 Jun 19
XBiotech Announces Pricing of Public Offering of Common Shares
4:48pm
8-K
athblbrkijdnv9wf9o
30 May 19
XBiotech Announces Public Offering of Common Shares
4:50pm
8-K
l7rrxppt3ab6 a2tr
30 May 19
Termination of a Material Definitive Agreement
4:19pm
8-K
g9m3c2r2c6 xpiftww27
1 May 19
Entry into a Material Definitive Agreement
5:20pm
8-K
sp3vycvxb u5pj32fn8
3 Apr 19
Termination of a Material Definitive Agreement
4:10pm
8-K
2xawd
24 Oct 18
XBiotech Announces Dismissal of Securities Class Action Suit
12:08pm
8-K
aad238mc1zpa
21 Jun 18
Submission of Matters to a Vote of Security Holders
2:18pm